Xiao Wei Teng

1.0k total citations
24 papers, 890 citations indexed

About

Xiao Wei Teng is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Xiao Wei Teng has authored 24 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Pharmacology. Recurrent topics in Xiao Wei Teng's work include Pharmacological Effects and Toxicity Studies (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Xiao Wei Teng is often cited by papers focused on Pharmacological Effects and Toxicity Studies (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Xiao Wei Teng collaborates with scholars based in United States, Canada and Australia. Xiao Wei Teng's co-authors include Neal M. Davies, Thomas K. H. Chang, Frank S. Abbott, Vincent Tong, Kathryn Roupe, Jaime A. Yáñez, Stephen W.J. Wang, Tony K. L. Kiang, David J. Cutler and Marc W. Fariss and has published in prestigious journals such as The FASEB Journal, Free Radical Biology and Medicine and The Journal of Pediatrics.

In The Last Decade

Xiao Wei Teng

24 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao Wei Teng United States 18 287 269 155 127 120 24 890
D. R. Krishna India 20 277 1.0× 134 0.5× 325 2.1× 45 0.4× 213 1.8× 77 1.4k
Wan Gyoon Shin South Korea 20 211 0.7× 197 0.7× 188 1.2× 33 0.3× 118 1.0× 62 1.2k
Shiyin Yee United States 9 447 1.6× 78 0.3× 141 0.9× 85 0.7× 259 2.2× 13 1.2k
Nobuo Inotsume Japan 17 212 0.7× 159 0.6× 243 1.6× 39 0.3× 221 1.8× 90 1.1k
Elke Störmer Germany 17 168 0.6× 257 1.0× 491 3.2× 77 0.6× 425 3.5× 18 1.2k
Nadia Soukhova United States 14 302 1.1× 137 0.5× 720 4.6× 82 0.6× 380 3.2× 18 1.4k
Tomohiro Nabekura Japan 20 555 1.9× 177 0.7× 299 1.9× 45 0.4× 465 3.9× 64 1.4k
Chang‐Ik Choi South Korea 22 313 1.1× 92 0.3× 556 3.6× 70 0.6× 261 2.2× 70 1.4k
Adam L. VanWert United States 13 243 0.8× 173 0.6× 129 0.8× 22 0.2× 311 2.6× 22 877
Dongsheng Ouyang China 24 459 1.6× 110 0.4× 492 3.2× 55 0.4× 186 1.6× 59 1.3k

Countries citing papers authored by Xiao Wei Teng

Since Specialization
Citations

This map shows the geographic impact of Xiao Wei Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Wei Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Wei Teng more than expected).

Fields of papers citing papers by Xiao Wei Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Wei Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Wei Teng. The network helps show where Xiao Wei Teng may publish in the future.

Co-authorship network of co-authors of Xiao Wei Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Wei Teng. A scholar is included among the top collaborators of Xiao Wei Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Wei Teng. Xiao Wei Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kiang, Tony K. L., et al.. (2011). Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: Role of biotransformation and temporal relationship with onset of toxicity. Toxicology and Applied Pharmacology. 252(3). 318–324. 47 indexed citations
3.
4.
Bonin, Antonio M., Jaime A. Yáñez, Chie Fukuda, et al.. (2009). Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper–indomethacin in rats. Cancer Chemotherapy and Pharmacology. 66(4). 755–764. 39 indexed citations
5.
Roupe, Kathryn, Jaime A. Yáñez, Xiao Wei Teng, & Neal M. Davies. (2006). Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. Journal of Pharmacy and Pharmacology. 58(11). 1443–1450. 75 indexed citations
6.
Yáñez, Jaime A., Xiao Wei Teng, Kathryn Roupe, & Neal M. Davies. (2005). Stereospecific high-performance liquid chromatographic analysis of hesperetin in biological matrices. Journal of Pharmaceutical and Biomedical Analysis. 37(3). 591–595. 43 indexed citations
7.
Tong, Vincent, Xiao Wei Teng, Thomas K. H. Chang, & Frank S. Abbott. (2005). Valproic Acid II: Effects on Oxidative Stress, Mitochondrial Membrane Potential, and Cytotoxicity in Glutathione-Depleted Rat Hepatocytes. Toxicological Sciences. 86(2). 436–443. 127 indexed citations
8.
Tong, Vincent, et al.. (2005). Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in rats. Free Radical Biology and Medicine. 38(11). 1471–1483. 14 indexed citations
9.
Tong, Vincent, Xiao Wei Teng, Thomas K. H. Chang, & Frank S. Abbott. (2005). Valproic Acid I: Time Course of Lipid Peroxidation Biomarkers, Liver Toxicity, and Valproic Acid Metabolite Levels in Rats. Toxicological Sciences. 86(2). 427–435. 123 indexed citations
10.
Teng, Xiao Wei, et al.. (2005). Pharmacokinetics and tissue distribution of d‐alpha‐tocopheryl succinate formulations following intravenous administration in the rat. Biopharmaceutics & Drug Disposition. 26(5). 195–203. 11 indexed citations
11.
Chang, Thomas K. H., Jie Chen, & Xiao Wei Teng. (2005). DISTINCT ROLE OF BILOBALIDE AND GINKGOLIDE A IN THE MODULATION OF RAT CYP2B1 AND CYP3A23 GENE EXPRESSION BY GINKGO BILOBA EXTRACT IN CULTURED HEPATOCYTES. Drug Metabolism and Disposition. 34(2). 234–242. 33 indexed citations
12.
13.
Roupe, Kathryn, Xiao Wei Teng, Xing Fu, Gary G. Meadows, & Neal M. Davies. (2004). Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation. Biomedical Chromatography. 18(8). 486–491. 42 indexed citations
14.
Yáñez, Jaime A., Xiao Wei Teng, Kathryn Roupe, Marc W. Fariss, & Neal M. Davies. (2004). Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase -2.. PubMed. 6(3). 308–14. 55 indexed citations
15.
Teng, Xiao Wei & Neal M. Davies. (2004). High-performance liquid chromatographic analysis of a selective cyclooxygenase-1 inhibitor SC-560 in rat serum: application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 35(5). 1143–1147. 3 indexed citations
16.
Davies, Neal M., Xiao Wei Teng, & Neil M. Skjodt. (2003). Pharmacokinetics of Rofecoxib. Clinical Pharmacokinetics. 42(6). 545–556. 21 indexed citations
17.
Teng, Xiao Wei, David J. Cutler, & Neal M. Davies. (2003). Mometasone furoate degradation and metabolism in human biological fluids and tissues. Biopharmaceutics & Drug Disposition. 24(8). 321–333. 23 indexed citations
18.
Teng, Xiao Wei, Stephen W.J. Wang, & Neal M. Davies. (2003). Stereospecific high-performance liquid chromatographic analysis of flurbiprofen: application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 33(1). 95–100. 31 indexed citations
19.
Teng, Xiao Wei, Stephen W.J. Wang, & Neal M. Davies. (2003). Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum. Journal of Chromatography B. 796(2). 225–231. 29 indexed citations
20.
Teng, Xiao Wei, Kuncoro Foe, Kenneth Brown, David J. Cutler, & Neal M. Davies. (2001). High-performance liquid chromatographic analysis of mometasone furoate and its degradation products. Journal of Pharmaceutical and Biomedical Analysis. 26(2). 313–319. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. R. Krishna Breakdown of academic impact, for papers by Wan Gyoon Shin Breakdown of academic impact, for papers by Shiyin Yee Breakdown of academic impact, for papers by Nobuo Inotsume Breakdown of academic impact, for papers by Elke Störmer Breakdown of academic impact, for papers by Nadia Soukhova Breakdown of academic impact, for papers by Tomohiro Nabekura Breakdown of academic impact, for papers by Chang‐Ik Choi Breakdown of academic impact, for papers by Adam L. VanWert Breakdown of academic impact, for papers by Dongsheng Ouyang
Rankless by CCL
2026